Cyproheptadine, an antihistaminic drug, inhibits proliferation of hepatocellular carcinoma cells by blocking cell cycle progression through the activation of P38 MAP kinase

BACKGROUND: Hepatocellular carcinoma (HCC) is a major cause of cancer deaths worldwide. However, current chemotherapeutic drugs for HCC are either poorly effective or expensive, and treatment with these drugs has not led to satisfactory outcomes. In a 2012 case report, we described our breakthrough...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Yu-Min, Feng, Chin-Wen, Chen, Syue-Yi, Hsieh, Hsiao-Yen, Chen, Yu-Hsin, Hsu, Cheng-Da
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4383201/
https://www.ncbi.nlm.nih.gov/pubmed/25886177
http://dx.doi.org/10.1186/s12885-015-1137-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4383201/
https://www.ncbi.nlm.nih.gov/pubmed/25886177
http://dx.doi.org/10.1186/s12885-015-1137-9

Ejemplares similares